CDTX vs ENPH · rev $1.3M vs P/E 56, rev $1.47B
Cidara Therapeutics Inc (CDTX) versus Enphase Energy Inc (ENPH) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Enphase Energy Inc (ENPH) is a solar company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported ENPH revenue for 2025-12-31 was $1.47B. Net income was $172.1M. Revenue was up 10.7% from 2024-12-31 to 2025-12-31. ENPH currently screens at market cap $7.39B and trailing P/E 55.5.
CDTX currently screens at market cap $6.96B. ENPH currently screens at market cap $7.39B and trailing P/E 55.5.
Not investment advice. Open the CDTX and ENPH stock pages for the full models.
Not investment advice.